NCT06986447View on ClinicalTrials.gov

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Not yet recruitingOBSERVATIONAL

Enrollment

1,689

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

January 31, 2029

Conditions

Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)MetALD

All Listed Sponsors

lead

HRI-MAIL-NIT

INDUSTRY

NCT06986447 - Assessment of Non-Invasive Testing in Major Liver-Related Outcomes | Biotech Hunter | Biotech Hunter